SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1444>> Finally in the Bear Sterns presentation of 9/17/02, it was stated that scaram(o)uche-3/22/2003
1443Thanks to both of you. By the way, here's a pretty good read, if you aren&#microcapfun-3/22/2003
1442>> Rick's theory is the the two mAbs are binding slightly different epscaram(o)uche-3/22/2003
1441Corvertible program Listening to Ken Bates' presentation at SG Cowen, I absIcebrg-3/22/2003
1440>>Does anyone have reason for any optimism regarding MLN02 or is it appropIcebrg-3/22/2003
1439MLN02 The Phase II MLN02 trial for Crohn's disease didn't meet its primmicrocapfun-3/22/2003
1438Press Release Source: StayinFront StayinFront to Provide Rapid Deployment of Cyojim-3/18/2003
1437MLNM's CEO Declines Bonus For 2002 Tuesday March 18, 1:12 pm ET WASHINGTONIcebrg-3/18/2003
1436SGP's mfg problems. This was mentioned already in the Q3 PR. <i>InteIcebrg-3/16/2003
1435From the 10-K: <i> One of the manufacturers that performs fill/finish andmicrocapfun-3/16/2003
1434Yes, it was remarked on at the time - although Elanesque was not a phrase then cnigel bates-3/15/2003
1433MLNM and XOMA It is almost something Elanesque over their collaboration scheme.Icebrg-3/15/2003
1432From XOMA 10K - <i>...Our financing arrangement with Millennium includes nigel bates-3/15/2003
1431Some individual biotech stocks like MLNM were big gainers this week. At the closblackmerlin-3/15/2003
1430Accelerated Approval <b> Companies that win so-called accelerated approvamicrocapfun-3/15/2003
1429Gotcha - thanks. >>Importantly, the parental myeloma cells as well as hummicrocapfun-3/15/2003
1428I was referring to that one and this one (sorry about formatting): Abstract Numtuck-3/15/2003
1427>>AACR presentations include some solid tumor data on PS341. Seems as thoumicrocapfun-3/14/2003
1426Furthermore this Robert Green seems to have the impression that ABT just recentlmicrocapfun-3/14/2003
1425The implication that ABT is a better way to play MLNM is absurd - even if MLNM wLondo-3/14/2003
1424OT: Thanks. Usually this Briefing writer has good insight. I wondered if I was Ian@SI-3/14/2003
1423Croatian. "As I see it..." respond blind man. Author is not only bliMiljenko Zuanic-3/14/2003
1422Tuck, Several factors indicate synergy in activity between 341 and cytotoxic/cytMiljenko Zuanic-3/14/2003
1421<i>"Kako sam ti rekao...", odgovori mu SLIJEPI! </i> GeezIan@SI-3/14/2003
1420AACR presentations include some solid tumor data on PS341. Seems as though it wtuck-3/14/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):